<DOC>
	<DOCNO>NCT02409732</DOCNO>
	<brief_summary>To evaluate safety efficacy PDT blue light topical Levulan treatment actinic cheilitis .</brief_summary>
	<brief_title>Photodynamic Therapy ( PDT ) With Levulan Blue Light Treatment Actinic Cheilitis</brief_title>
	<detailed_description>The study consist screen visit , three schedule treatment , two schedule office visit . There three-day window period schedule visit order accommodate subject 's schedule unforeseen schedule conflict . 1 . Visit 1 ( Screening ) : Subjects screen study two week Visit 2 ( Baseline ) . During screening , study review , write informed consent obtain , eligibility confirm . If applicable , washout prohibit medication treatment determine visit . 2 . Visit 2 ( Baseline ) : Following sign , write informed consent confirmation eligibility , subject lip photograph . Medical history , dermatologic exam , urine pregnancy test ( applicable ) , review concomitant medication , clinical evaluation , tolerability assessment perform visit . Study medication application clean skin follow ninety minute incubation period occlusion . Subsequently , patient expose blue light therapy 16 minute 40 second . Post-therapy assessment perform afterwards , well education appropriate sun protection method . 3 . Visits 3-4 : Subjects return every six week two additional treatment . Treatment discontinue patient achieve clinical clearance . Tolerability assessment , study medication application , blue light therapy , post-therapy assessment , photograph perform . 4 . Visit 5-6 ( End Study ) : Subjects return 12 24 week last treatment clinical evaluation , tolerability assessment , photograph .</detailed_description>
	<mesh_term>Cheilitis</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>Must able understand voluntarily sign informed consent form Must male female â‰¥ 18 year age time consent Must able adhere study visit schedule protocol requirement Must diagnosis actinic cheilitis histopathological evaluation biopsy specimen clinical presentation Inability provide voluntarily consent mentally incompetent Active herpes labialis lesion Subjects condition place subject unacceptable risk he/she participate study , confound ability interpret data study Subjects skin condition might affect evaluation study disease Pregnant breastfeed female subject Subjects use investigational medication within one month prior study entry Subjects previously expose PDT and/or topical Levulan therapy treatment actinic cheilitis Subjects use local therapy ( e.g . cryotherapy ) topical treatment ( e.g . 5 % fluorouracil ) within three month study entry Subjects use oral photosensitize drug ( e.g . Declomycin ) within six month study entry Subjects currently use photosensitize agent ( e.g . thiazide , tetracycline , fluoroquinolones , phenothiazine , sulfonamide ) risk augment photosensitivity Subjects frequently expose ultraviolet radiation ( e.g . lifeguard , construction worker , frequent sunbed user , etc . ) Subjects history cutaneous photosensitization , porphyria , hypersensitivity porphyrin , photodermatosis Subjects know hypersensitivity Levulan Subjects immunocompromised</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Actinic cheilitis</keyword>
	<keyword>Photodynamic therapy</keyword>
	<keyword>Levulan</keyword>
	<keyword>Blue light</keyword>
</DOC>